Allergan Pharmaceuticals Ireland Unlimited

Form 483 issued December 17, 2019 · Westport, Ireland

Inspection
Dec 17, 2019
Investigator
Wayne Seifert
Observations
3
Pages
2
FEI number
3002806285

In short: On December 17, 2019, FDA issued a Form 483 with 3 observations to Allergan Pharmaceuticals Ireland Unlimited in Westport, Ireland (FEI 3002806285) after an inspection that ran Dec 17, 2019. The investigator was Wayne Seifert. Most observations concern facilities & equipment and laboratory controls.

At a glance

2 of 3 observations on this 483 concern facilities & equipment.

Facilities & equipment2
Laboratory controls1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Your examination of samples did not assure that the drug…

  2. 02

    On 12/09/2019, discoloration was observed on () 4) supporting the (>) (4) inside the Biologics®)@ You…

  3. 03

    Equipment and utilities are not…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Allergan Pharmaceuticals Ireland Unlimited?

FDA listed 3 observations on this Form 483, mostly about facilities & equipment and laboratory controls. The opening words of each observation are shown on this page.

Who inspected Allergan Pharmaceuticals Ireland Unlimited?

Wayne Seifert is named on this Form 483, for the inspection of Dec 17, 2019. Each investigator has a profile showing what they cite most.

When was Allergan Pharmaceuticals Ireland Unlimited inspected by FDA?

The inspection ran Dec 17, 2019, and the Form 483 is dated December 17, 2019.

How do I get the full Form 483 for Allergan Pharmaceuticals Ireland Unlimited?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free